Imaging Bone and Soft Tissue Tumors with the Proliferation Marker [18F]Fluorodeoxythymidine
نویسندگان
چکیده
منابع مشابه
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine.
PURPOSE We have determined the ability of positron emission tomography (PET) with the thymidine analogue 3'-deoxy-3'[18F]fluorothymidine (FLT) to detect manifestation sites of bone and soft tissue tumors, to assess tumor grading, and to differentiate malignant from benign tumors. MATERIALS AND METHODS In this prospective bicenter trial, FLT-PET was done in 22 patients with established or susp...
متن کاملImaging of soft-tissue tumors.
The objective of this review is to highlight the major imaging characteristics of the main soft-tissue sarcoma histotypes observed in the group "Sarcomi" of the Istituto Oncologico Veneto in the last 5 years. A literature review was performed using PubMed and textbooks. Radiological imaging can guide the diagnosis for the subset of lesions that have typical clinical and imaging features. Soft-t...
متن کاملCytopathology of soft tissue and bone tumors.
Follow up what we will offer in this article about cytopathology of soft tissue and bone tumors. You know really that this book is coming as the best seller book today. So, when you are really a good reader or you're fans of the author, it does will be funny if you don't have this book. It means that you have to get this book. For you who are starting to learn about something new and feel curio...
متن کاملBone changes associated with soft-tissue tumors of the hand.
The purpose of this study was to clarify clinical and radiographic features of bone changes associated with soft-tissue tumors of the hand. We reviewed clinical records and radiographs of 115 patients who had undergone operations for soft-tissue tumors or tumorous conditions of the hand. Bone changes were detected in the radiographs of 21 of the 115 patients. Giant cell tumor of tendon sheath w...
متن کاملLimb preservation in patients with bone and soft tissue tumors.
Dr Siegel is from the Section of Orthopedic Oncology, University of Alabama at Birmingham, Orthopedics Specialties, Birmingham, Alabama. Dr Siegel has no relevant fi nancial relationships to disclose. Correspondence should be addressed to: Herrick J. Siegel, MD, Orthopedic Oncology, UAB Orthopedics Specialties Bldg, 1313 13th St S, Birmingham, AL, 35205 ([email protected]). doi: 10.3...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Cancer Research
سال: 2008
ISSN: 1078-0432,1557-3265
DOI: 10.1158/1078-0432.ccr-07-4294